Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?-Reference-Cited by-同舟云学术

Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?

Published:2023-03 Issue: Volume:542 Page:117270
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Rius Bilbao Leire,Valladares Gomez Carmen,Aguirre Larracoechea Urko,Pereira Arias Jose Gregorio,Arredondo Calvo Pablo,Urdaneta Salegui Luis Felipe,Escobal Tamayo Victor,Sanz Jaka Juan Pablo,Recio Ayesa Adrian,Mar Medina Javier,Mar Medina Carmen

Funder

Basque Foundation for Health Innovation and Research

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference38 articles.

1. Epidemiology of Prostate Cancer;Rawla;World J. Oncol.,2019

2. Asymptomatic incidence and duration of prostate cancer;Etzioni;Am. J. Epidemiol.,1998

3. Reconsidering Prostate Cancer Mortality - The Future of PSA Screening;Welch;N. Engl. J. Med.,2020

4. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019;Gandaglia;Eur. Urol.,2019

5. A systematic review of the diagnostic accuracy of prostate specific antigen;Harvey;BMC Urology,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in multiparametric magnetic resonance imaging combined with biomarkers for the diagnosis of high-grade prostate cancer;Frontiers in Surgery;2024-07-16

2. Serum (‐2)proPSA/freePSAratio, (‐2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate‐specific antigen 2–10 ng/mL;The Prostate;2024-05-26

3. Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancer;World Journal of Urology;2024-03-13

4. Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects;The World Journal of Men's Health;2024